Status:
COMPLETED
Efficacy and Safety of Nebivolol (Added to Lisinopril or Losartan) in Hypertensive Patients
Lead Sponsor:
Forest Laboratories
Conditions:
Hypertension
Eligibility:
All Genders
18-85 years
Phase:
PHASE4
Brief Summary
This study will assess blood pressure reduction with nebivolol or placebo in patients taking lisinopril or losartan.
Eligibility Criteria
Inclusion
- Male or female, ambulatory outpatients 18-85 years old at screening
- Have a history of hypertension
- Qualifying laboratory results
Exclusion
- Severe hypertension, including chronic kidney disease
- Documented congestive heart failure
- Have clinically significant respiratory, liver, or heart disease
- History of stroke, heart attack, or heart surgery in the last 6 months
- Have a history of hypersensitivity to nebivolol or other beta blockers.
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
491 Patients enrolled
Trial Details
Trial ID
NCT00734630
Start Date
August 1 2008
End Date
May 1 2010
Last Update
April 26 2011
Active Locations (75)
Enter a location and click search to find clinical trials sorted by distance.
1
Forest Investigative Site 070
Gulf Shores, Alabama, United States, 36535
2
Forest Investigative Site 092
Huntsville, Alabama, United States, 35801
3
Forest Investigative Site 058
Mesa, Arizona, United States, 85206
4
Forest Investigative Site 059
Tempe, Arizona, United States, 85282